CD8A and neoplasm: On the other hand, IL-10 plays a key role in inhibiting tumor growth by recruiting and activating cytotoxic CD8+ T cells and NK cells, enhancing immune memory, suppressing pro-inflammatory M1 macrophages and Th17 cells, reducing pro-angiogenic factor synthesis, and limiting pro-inflammatory cytokine release that promotes tumor progression [61].